CoreRx, a leader in early drug contract development, has expanded manufacturing capabilities to include 15-cubic foot and 30-cubic foot V-shell blenders, a 43-station high speed tablet press, high speed encapsulation and a 40-inch solvent-capable coating pan. The additional equipment train will allow for increased clinical batch sizes in support of growing client demand.  The additional equipment will allow CoreRx scientists to manufacture batch sizes of up to one million solid dosage units per day.

LARGO, FL (Nov. 30, 2010) – Pharmaceutical manufacturer CoreRx will soon add 55 high-wage jobs to Pinellas County, Florida, while retaining its current 16 Tampa Bay employees.  The new jobs result from a planned expansion that also necessitates a new, larger location.

CoreRx continues to grow in 2010, providing unsurpassed contract pharmaceutical development services to the pharma & biotech industries. This is more evident with the latest announcement of the Tampa Bay Business Journal announcement of the Fast 50 nominees.

Common “First in Man” approaches vs. The Lost Art of Formulation Development

In today’s market, pharmaceutical and biotech companies are being asked to do more…with less.  Diminishing resources, pipelines, competition, and increased regulatory hurdles are forcing us to rethink our strategy. We must work smarter, not harder.